Using video logs to promote HIV prevention among Black women in Texas
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
This study is testing whether using video logs can help Black women in Texas feel more comfortable starting a medication that prevents HIV.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 78 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | The University of Texas Medical Branch, Galveston Academic / other |
| Locations | 1 site (Galveston, Texas) |
| Trial ID | NCT06864689 on ClinicalTrials.gov |
What this trial studies
This intervention aims to enhance the willingness and actual initiation of pre-exposure prophylaxis (PrEP) among cisgender Black women (CBW) in Houston/Harris County. It employs a video-log series tailored to both CBW and healthcare providers to improve health communication and increase PrEP prescriptions. The study includes a pilot randomized controlled trial and a social media campaign to engage participants and assess the feasibility and impact of the intervention. Focus groups and interviews will inform the development of health messages for the project.
Who should consider this trial
Good fit: Ideal candidates for this study are cisgender Black women aged 18 and older who meet CDC criteria for PrEP eligibility.
Not a fit: Patients who are not eligible for PrEP or have received a prescription for PrEP within the last 12 months may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase PrEP uptake among Black women, thereby reducing HIV transmission rates in this population.
How similar studies have performed: While there have been various interventions aimed at increasing PrEP uptake, this specific approach using video logs and tailored messaging is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Selection criteria for participation in pilot RCT. Eligible participants in the category for CBW must: 1. be assigned female sex at birth 2. be ≥18 years of age 3. be PrEP-eligible according to CDC criteria 4. be fluent in English 5. have a phone or internet access Eligible participants (i.e., PrEP-eligible CBW) must not: 1. be unable to provide informed consent/assent for participation (i.e., have severe cognitive impairment that would interfere with their ability to consent or understand study procedures) 2. have psychological distress that would prohibit them from participating in the study 3. be unable or unwilling to meet study requirements 4. be ineligible for PrEP 5. received a prescription for PrEP within 12 months 6. be unable to fill out the evaluation independently Note: All patients who are excluded will receive usual care in the clinical setting. Eligible participants in the HCP category must: 1) be licensed and board-certified HCPs at participating clinics
Where this trial is running
Galveston, Texas
- University of Texas Medical Branch, Galveston — Galveston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Mandy Hill, DrPH,MPH,HIVPCP — University of Texas Medical Branch, Galveston
- Study coordinator: Mandy Hill, Dr.PH, MPH, HIVPCP
- Email: majhill@utmb.edu
- Phone: 409-266-0509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.